A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
ImmunityBio, Inc.
AbbVie
OncoC4, Inc.
Eli Lilly and Company
NanOlogy, LLC
Rainier Therapeutics